Pseudomyxoma peritonei; een zeldzame tumor, te behandelen met cytoreductieve chirurgie en hypertherme intraperitoneale chemotherapie
(2007) In Nederlands Tijdschrift voor Geneeskunde 151(7). p.418-423- Abstract
Three patients, men aged 47 and 30 and a woman aged 48 years, presented with appendicitis-like symptoms, progressive abdominal distension, and an ovarian pelvic mass, respectively. All three were diagnosed with pseudomyxoma peritonei. Treatment consisted of cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). After a mean follow-up of 64 months (range: 19-89) after initial treatment, the second patient had died of disease progression but the other two were alive and free of disease. Pseudomyxoma peritonei is a rare disease, characterised by progressive intraperitoneal accumulation of mucinous ascites, produced by a mucinous tumour mass on the peritoneal surfaces. The primary tumour is usually a mucinous... (More)
Three patients, men aged 47 and 30 and a woman aged 48 years, presented with appendicitis-like symptoms, progressive abdominal distension, and an ovarian pelvic mass, respectively. All three were diagnosed with pseudomyxoma peritonei. Treatment consisted of cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). After a mean follow-up of 64 months (range: 19-89) after initial treatment, the second patient had died of disease progression but the other two were alive and free of disease. Pseudomyxoma peritonei is a rare disease, characterised by progressive intraperitoneal accumulation of mucinous ascites, produced by a mucinous tumour mass on the peritoneal surfaces. The primary tumour is usually a mucinous adenoma of the appendix. Treatment by cytoreductive surgery and HIPEC can result in a 5-year survival rate of more than 80%, depending on the histopathology and the completeness of the cytoreduction. Recognising pseudomyxoma peritonei in an early stage, when complete cytoreduction is still achievable, may result in a considerable improvement in survival.
(Less)
- author
- Smeenk, R. M. ; Verwaal, V. J. LU and Zoetmulder, F. A.N.
- alternative title
- Pseudomyxoma peritonei; a rare tumour that can be treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
- publishing date
- 2007-02-17
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Adult, Antineoplastic Agents/therapeutic use, Combined Modality Therapy, Fatal Outcome, Female, Humans, Hyperthermia, Induced/methods, Male, Middle Aged, Peritoneal Neoplasms/diagnosis, Pseudomyxoma Peritonei/diagnosis, Treatment Outcome
- in
- Nederlands Tijdschrift voor Geneeskunde
- volume
- 151
- issue
- 7
- pages
- 6 pages
- publisher
- Bohn Stafleu van Loghum
- external identifiers
-
- pmid:17343142
- scopus:33847384541
- ISSN
- 0028-2162
- language
- Dutch
- LU publication?
- no
- additional info
- Original language: Dutch
- id
- c2795361-1c5d-4ce6-8b6e-e2bf0844205f
- date added to LUP
- 2022-04-12 09:52:54
- date last changed
- 2024-01-06 23:51:15
@article{c2795361-1c5d-4ce6-8b6e-e2bf0844205f,
abstract = {{<p>Three patients, men aged 47 and 30 and a woman aged 48 years, presented with appendicitis-like symptoms, progressive abdominal distension, and an ovarian pelvic mass, respectively. All three were diagnosed with pseudomyxoma peritonei. Treatment consisted of cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). After a mean follow-up of 64 months (range: 19-89) after initial treatment, the second patient had died of disease progression but the other two were alive and free of disease. Pseudomyxoma peritonei is a rare disease, characterised by progressive intraperitoneal accumulation of mucinous ascites, produced by a mucinous tumour mass on the peritoneal surfaces. The primary tumour is usually a mucinous adenoma of the appendix. Treatment by cytoreductive surgery and HIPEC can result in a 5-year survival rate of more than 80%, depending on the histopathology and the completeness of the cytoreduction. Recognising pseudomyxoma peritonei in an early stage, when complete cytoreduction is still achievable, may result in a considerable improvement in survival.</p>}},
author = {{Smeenk, R. M. and Verwaal, V. J. and Zoetmulder, F. A.N.}},
issn = {{0028-2162}},
keywords = {{Adult; Antineoplastic Agents/therapeutic use; Combined Modality Therapy; Fatal Outcome; Female; Humans; Hyperthermia, Induced/methods; Male; Middle Aged; Peritoneal Neoplasms/diagnosis; Pseudomyxoma Peritonei/diagnosis; Treatment Outcome}},
language = {{dut}},
month = {{02}},
number = {{7}},
pages = {{418--423}},
publisher = {{Bohn Stafleu van Loghum}},
series = {{Nederlands Tijdschrift voor Geneeskunde}},
title = {{Pseudomyxoma peritonei; een zeldzame tumor, te behandelen met cytoreductieve chirurgie en hypertherme intraperitoneale chemotherapie}},
volume = {{151}},
year = {{2007}},
}